Il 1 Blocking Agents + Canakinumab Interaction
Majorinteraction on record
Description
Concomitant administration with other IL-1 blockers or IL-1 receptor antagonists is not recommended due to potential pharmacological interactions.
Mechanism
Overlapping IL-1 pathway inhibition
Source: NLP:canakinumab